LAVAL, Quebec, April 6, 2018 /PRNewswire/ -- Valeant
Pharmaceuticals International, Inc. (NYSE/TSX: VRX) ("Valeant")
will release its first-quarter 2018 financial results on
Tuesday, May 8, 2018. Valeant will
host a conference call and live web cast at 8:00 a.m. EDT to discuss the results and provide
a business update. All materials will be made available on the
Investor Relations section of the Valeant web site prior to the
start of the call.
Conference Call
Details
|
|
Date:
|
Tuesday, May 8,
2018
|
Time:
|
8:00 a.m.
EDT
|
Webcast:
|
http://ir.valeant.com/events-and-presentations
|
Participant Event
Dial-in:
|
(844) 428-3520 (North
America)
|
|
(409) 767-8386
(International)
|
Participant
Passcode:
|
6185877
|
Replay
Dial-in:
|
(855) 859-2056 (North
America)
|
|
(404) 537-3406
(International)
|
Replay
Passcode:
|
6185877 (replay
available until July 8, 2018)
|
About Valeant
Valeant Pharmaceuticals International,
Inc. (NYSE/TSX: VRX) is a global company whose mission is to
improve people's lives with our health care products. We develop,
manufacture and market a range of pharmaceutical, medical device
and over-the-counter products, primarily in the therapeutic areas
of eye health, gastroenterology and dermatology. We are delivering
on our commitments as we build an innovative company dedicated to
advancing global health. More information can be found at
www.valeant.com.
Investor
Contact:
|
Media
Contact:
|
Arthur
Shannon
|
Lainie
Keller
|
arthur.shannon@valeant.com
|
lainie.keller@valeant.com
|
(514)
856-3855
|
(908)
927-0617
|
View original content with
multimedia:http://www.prnewswire.com/news-releases/valeant-will-release-first-quarter-2018-financial-results-on-may-8-300624661.html
SOURCE Valeant Pharmaceuticals International, Inc.